About Nonclinical Development Assistance, LLC (N-cDA)
Nonclinical Development Assistance (N-cDA) was founded in 2014 to assist with the operational needs of Preclinical Development in the Biopharmaceutical industry. N-cDA has over 25 years of biopharmaceutical drug development experience in academia, CROs, and private industry working with small molecules and biologics.
N-cDA incorporates its experience in the private sector, CROs, and academia to assist with the management of Preclinical Development including:
√ Preclinical Development Budget Management
√ CRO Relationship Building
√ Training of GLP and Study Managers
√ Building Cross-Functional Teams
√ Process Improvement
√ SOP Development
√ Archival Programs
Nonclinical Development Assistance offers PMI certified project management services (2013-2016). Additionally, Six Sigma certification allows N-cDA to be a powerhouse when preparing your preclinical programs for forward traction, specializing in:
√ Data Integrity Review for Modules 2 and 4
√ Generating Tabulated Summaries for NDAs
√ Working with Regulatory Operations
√ Documenting regulatory questions and responses from multiple agencies
√ Preparing and Publishing Safety Reports
√ Updating the clinicaltrial.gov website
√ Providing Project Management Expertise for GLP Inspection Readiness
√ Data Discovery
√ Preparing data for out-licensing
Nonclinical Development Assistance is a continuous force for study management conventions by oversight of review and quality control of nonclinical protocols through reporting and monitoring studies being conducted at CROs. Additionally, N-cDA’s ability to discuss and coordinate strategies with toxicologists allows N-cDA to prepare timelines for a multitude of programs making Nonclinical Development Assistance a formidable force for your preclinical programs.